Alkermes Plc All eyes today on Alkermes Plc (NASDAQ:ALKS) as the biopharmaceutical company announced positive phase 3 data for ALKS 5461, a pipeline drug …
Piper Jaffray and William Blair are joining the conversation on falling stocks Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and DXP Enterprises Inc (NASDAQ:DXPE) after volatile news has …
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors are having a rough day as the company just reported results from its second phase 3 for fostamatinib in ITP.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced plans to build a commercial organization to support the potential launch of fostamatinib, its oral SYK inhibitor, for …